Warner Chilcott: Clinical Trials

61 trials sponsored by Warner Chilcott, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

55 completed, 6 terminated. 32 Phase 3, 11 Phase 2, 10 Phase 1, 3 Not applicable, 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 3	32	Completed 31, Terminated 1
Phase 2	11	Completed 8, Terminated 3
Phase 1	10	Completed 9, Terminated 1
Not applicable	3	Completed 3
Phase 4	2	Completed 1, Terminated 1

Follow Warner Chilcott: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy Estradiol Vaginal Capsule (EVC), Placebo - Vulvovaginal Atrophy, Menopause	Phase 2	Completed	Warner Chilcott	203	2016-02-15	2017-08-23
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia WC3055, Placebo - Benign Prostatic Hyperplasia	Phase 2	Completed	Warner Chilcott	796	2013-08-01	2015-06-29
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia WC3011 Estradiol Vaginal Cream, Vehicle - Vulvovaginal Atrophy	Phase 3	Completed	Warner Chilcott	550	2013-04-12	2022-05-09
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction WC3036-11F/Alprostadil in Vehicle 2.5%, WC3036-12F/Alprostadil in Vehicle 0.5%, WC3036-13P/Vehicle Only 0.5% - Erectile Dysfunction	Phase 2	Terminated	Warner Chilcott	16	2013-02-01	2014-08-12
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women Vehicle, WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy	Phase 3	Completed	Warner Chilcott	576	2013-01-31	2022-05-09
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) WC3011 Estradiol Vaginal Cream - Vulvovaginal Atrophy	Phase 3	Completed	Warner Chilcott	309	2011-10-20	2022-05-09
Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women WC3011 Estradiol Vaginal Cream, Vehicle - Postmenopausal Vulvovaginal Atrophy	Phase 3	Completed	Warner Chilcott	722	2011-06-29	2022-05-09
Effect of Udenafil on Spermatogenesis Placebo, Udenafil - Spermatogenesis, Erectile Dysfunction	Phase 1	Completed	Warner Chilcott	239	2010-09-01	2011-11-30
Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin Doxycyline Hyclate tablet, Vibramycin (doxycyline hyclate) capsule - Urogential Chlamydia Trachomatis Infection	Phase 3	Completed	Warner Chilcott	495	2010-04-01	2012-01-27
Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors FRAX Assessment Tool - Osteoporosis, Osteopenia	Not applicable	Completed	Duquesne University	90	2010-02-01	2012-04-06
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy Udenafil 50 mg, Udenafil 100 mg, Udenafil 150 mg - Erectile Dysfunction	Phase 3	Completed	Warner Chilcott	1027	2010-01-01	2015-04-20
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis Asacol 400 mg - Ulcerative Colitis	Phase 3	Terminated	Warner Chilcott	39	2009-10-01	2012-05-25
Treatment of Erectile Dysfunction II Udenafil, Placebo - Erectile Dysfunction	Phase 3	Completed	Warner Chilcott	601	2009-09-01	2015-06-19
Treatment of Erectile Dysfunction I Udenafil, Placebo - Erectile Dysfunction	Phase 3	Completed	Warner Chilcott	618	2009-09-01	2011-12-22
Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure placebo, testosterone - Heart Failure	Phase 2	Terminated	Warner Chilcott	17	2009-07-01	2012-01-13
Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women 150 mg, 75 mg, 100 mg - Postmenopausal Osteoporosis	Phase 2	Completed	Warner Chilcott	205	2009-05-01	2015-06-29
Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food 35 mg risedronate DR tablet - Healthy	Phase 1	Completed	Warner Chilcott	101	2009-03-01	2011-10-12
A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects risedronate DR (Phase III clinical supply), risedronate 35 mg DR (Commercial Tablet) - Osteoporosis	Phase 1	Completed	Warner Chilcott	538	2009-01-01	2011-10-12
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis Asacol 400 mg - Ulcerative Colitis	Phase 3	Completed	Warner Chilcott	83	2008-12-01	2012-04-05
A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity Darifenacin - Neurogenic Detrusor Overactivity	Phase 2	Terminated	Warner Chilcott	35	2008-10-07	2022-06-09

Warner Chilcott: Clinical Trials

61 trials sponsored by Warner Chilcott, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

By phase and status

Trials newest first · largest first

Conditions studied

Interventions

Countries

Top investigators

Results publications